Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 450 JPY -0.16% Market Closed
Market Cap: 405.1B JPY
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Kobayashi Pharmaceutical Co Ltd stock under the Base Case scenario is 4 751.94 JPY. Compared to the current market price of 5 450 JPY, Kobayashi Pharmaceutical Co Ltd is Overvalued by 13%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
4 751.94 JPY
Overvaluation 13%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.4
P/S
P/S
Price to Sales
2.4
vs History
88
vs Industry
18
Median 3Y
3
Median 5Y
3.6
Industry
1
Forward
2.3
More Details
40.2
P/E
P/E
Price to Earnings
40.2
vs History
17
vs Industry
12
Median 3Y
31.6
Median 5Y
33
Industry
16.4
Forward
30.1
More Details
36
P/OCF
P/OCF
Price to OCF
36
vs History
14
vs Industry
9
Median 3Y
25
Median 5Y
29.3
Industry
11.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
5
Median 3Y
38.3
Median 5Y
39.1
Industry
17.6
More Details
1.9
P/B
P/B
Price to Book Value
1.9
vs History
95
vs Industry
30
Median 3Y
2.5
Median 5Y
3.3
Industry
1.5
More Details
2.1
EV/S
EV/S
Enterprise Value to Sales
2.1
vs History
92
vs Industry
23
Median 3Y
2.5
Median 5Y
3
Industry
1.1
Forward
1.9
More Details
3.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.9
vs History
87
vs Industry
39
Median 3Y
4.5
Median 5Y
5.4
Industry
3.7
More Details
10.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.3
vs History
96
vs Industry
31
Median 3Y
13.4
Median 5Y
15.5
Industry
9.6
Forward
12.1
More Details
13.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
13.7
vs History
92
vs Industry
28
Median 3Y
16.6
Median 5Y
18.6
Industry
12.5
More Details
30.2
EV/OCF
EV/OCF
Enterprise Value to OCF
30.2
vs History
15
vs Industry
11
Median 3Y
20.7
Median 5Y
24.9
Industry
11.9
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
5
Median 3Y
31.9
Median 5Y
32.7
Industry
15.1
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
95
vs Industry
25
Median 3Y
2.7
Median 5Y
4.2
Industry
1.2
More Details

Multiples Across Competitors

Competitors Multiples
Kobayashi Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Kobayashi Pharmaceutical Co Ltd
TSE:4967
405.1B JPY 2.4 40.2 10.3 13.7
FR
L'Oreal SA
PAR:OR
199.9B EUR 4.6 31.2 19.2 23.3
UK
Unilever PLC
LSE:ULVR
116.1B GBP 2.2 23.7 146.6 169.6
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR 8.7 51 36.3 39.8
UK
HALEON PLC
LSE:HLN
34.2B GBP 3 23.7 14.1 15.9
DE
Beiersdorf AG
XETRA:BEI
26.8B EUR 2.7 29.3 12.4 15.1
US
Estee Lauder Companies Inc
NYSE:EL
21.4B USD 1.4 -30.6 11.3 17.6
JP
Kao Corp
TSE:4452
2.8T JPY 1.7 26.1 11.2 17.9
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR 9.2 -286.1 42.2 45.3
CN
Giant Biogene Holding Co Ltd
HKEX:2367
79.3B HKD 13.4 36.1 27.9 28.4
IN
Dabur India Ltd
NSE:DABUR
858.9B INR 6.8 47.8 35.8 43.7
P/E Multiple
Earnings Growth PEG
JP
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Average P/E: 34.3
40.2
20%
2
FR
L'Oreal SA
PAR:OR
31.2
9%
3.5
UK
Unilever PLC
LSE:ULVR
23.7
14%
1.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
51
8%
6.4
UK
HALEON PLC
LSE:HLN
23.7
13%
1.8
DE
Beiersdorf AG
XETRA:BEI
29.3
12%
2.4
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -30.6
43%
N/A
JP
Kao Corp
TSE:4452
26.1
10%
2.6
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
Negative Multiple: -286.1 N/A N/A
CN
G
Giant Biogene Holding Co Ltd
HKEX:2367
36.1
25%
1.4
IN
Dabur India Ltd
NSE:DABUR
47.8
9%
5.3

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 248,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.